Chester County News and Community Website
MALVERN, PA — MAXONA Pharmaceuticals has received U.S. Food and Drug Administration clearance to begin a Phase 2 clinical trial of its investigational non-opioid pain therapy, advancing the company’s effort …
FDA Clears MAXONA Pain Drug for Phase 2 Trial Read More MALVERN, PA — MAXONA Pharmaceuticals has taken a key step toward advancing its flagship pain therapy, filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration …
MAXONA Pharmaceuticals Submits FDA Application for Non-Opioid Pain Treatment Read More MALVERN, PA — MAXONA Pharmaceuticals announced the formation of its Scientific Advisory Board (SAB) and the successful completion of its inaugural meeting, marking a significant milestone in the development of …
MAXONA Pharmaceuticals Advances Non-Opioid Pain Therapy with Launch of Scientific Advisory Board Read More MALVERN, PA — Maxona Pharmaceuticals has announced the issuance of Patent No. 12,226,421 by the United States Patent and Trademark Office (USPTO) for MAX-001, the company’s breakthrough non-opioid, non-NSAID oral therapy …
Maxona Pharmaceuticals Secures New Patent for Innovative Pain Therapy Read More